Mumbai has emerged as a significant hub for pharmaceutical production , with several firms specializing in the development of Active Pharmaceutical Ingredients (APIs). Notably, a number of leading businesses are focused on the supply of Finasteride API (CAS No: 98319-26-7), meeting the worldwide dem